title: The use of a scoring system to guide thromboprophylaxis in a high-risk pregnant population.
abstract: Guidelines for thromboprophylaxis in pregnancy are usually based upon clinical observations and expert opinion. For optimal impact, their use must be attended by consistency in the advice given to women. In this observational study, we evaluated the performance of a scoring system, used as a guide for clinicians administering dalteparin to pregnant women at increased risk of venous thromboembolism. The work included 47 women treated with dalteparin prior to adoption of the scoring system and 58 women treated with dalteparin after its adoption. The indication for thromboprophylaxis was recorded in each case together with details of the regimen employed, obstetric, and haematological outcomes. The main outcome measure was to determine whether consistency improved after adoption of the scoring system. We also recorded the occurrence of any new venous thromboembolism, haemorrhage, the use of regional anaesthesia during labour, evidence of allergy, and thrombocytopenia. We found that use of the scoring system improved the consistency of advice and increased the mean duration of thromboprophylaxis. None of the subjects suffered venous thromboembolism after assessment using the scoring system. There was no increase in obstetric or anaesthetic morbidity when dalteparin was given antenatally period and no evidence of heparin-induced thrombocytopenia.
authors.affiliation: Department of Women's Services and Royal Victoria Infirmary, Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne NE1 4LP, UK.
authors.forename: D
authors.initials: D
authors.lastname: Schoenbeck
authors.forename: A
authors.initials: A
authors.lastname: Nicolle
authors.forename: K
authors.initials: K
authors.lastname: Newbegin
authors.forename: J
authors.initials: J
authors.lastname: Hanley
authors.forename: A D
authors.initials: AD
authors.lastname: Loughney
references.citation: N Engl J Med. 2000 Nov 16;343(20):1439-44
references.pmid: 11078768
references.citation: Baillieres Clin Obstet Gynaecol. 1997 Sep;11(3):601-10
references.pmid: 9488794
references.citation: Thromb Haemost. 1997 Oct;78(4):1183-8
references.pmid: 9364982
references.citation: Am J Obstet Gynecol. 1997 May;176(5):1062-8
references.pmid: 9166169
references.citation: Lancet. 1999 Apr 3;353(9159):1167-73
references.pmid: 10209995
references.citation: Blood Coagul Fibrinolysis. 1991 Apr;2(2):273-8
references.pmid: 1893059
references.citation: Thromb Haemost. 1999 Apr;81(4):527-31
references.pmid: 10235433
references.citation: Acta Anaesthesiol Scand. 1992 Oct;36(7):605-9
references.pmid: 1332355
references.citation: J Thromb Haemost. 2005 May;3(5):949-54
references.pmid: 15869590
references.citation: Ann Intern Med. 2005 Nov 15;143(10):697-706
references.pmid: 16287790
references.citation: Eur J Obstet Gynecol Reprod Biol. 1996 Apr;65(2):171-4
references.pmid: 8730619
references.citation: Br J Haematol. 2001 Sep;114(3):512-28
references.pmid: 11552975
references.citation: Cochrane Database Syst Rev. 2002;(2):CD001689
references.pmid: 12076417
references.citation: Thromb Haemost. 1998 Jun;79(6):1166-70
references.pmid: 9657443
references.citation: Br J Obstet Gynaecol. 1999 Aug;106(8):756-66
references.pmid: 10453824
references.citation: Am J Obstet Gynecol. 2000 May;182(5):1073-5
references.pmid: 10819831
references.citation: N Engl J Med. 1995 May 18;332(20):1330-5
references.pmid: 7715641
references.citation: Br J Clin Pharmacol. 2001 Dec;52(6):708-10
references.pmid: 11736885
references.citation: BJOG. 2000 Sep;107(9):1116-21
references.pmid: 11002955
references.citation: Br J Obstet Gynaecol. 1990 Apr;97(4):338-41
references.pmid: 2340259
references.citation: Br J Obstet Gynaecol. 1986 Apr;93(4):348-52
references.pmid: 3964611
references.citation: Am J Clin Dermatol. 2001;2(2):69-75
references.pmid: 11705306